PRIMARY STUDY
The endocannabinoid system and NGF are involved in the mechanism of action of resveratrol: a multi-target nutraceutical with therapeutic potential in neuropsychiatric disorders
Key Findings: Resveratrol similar to amitriptyline, affects brain nerve growth factor (NGF) and ECS-based signaling via CB1.
Type of Study: Animal Study
Study Result: Positive
Research Location(s): Iran
Year of Pub: 2023
Cannabinoids Studied: Resveratrol
Phytocannabinoid Source: Not Applicable
Receptors Studied: CB1
Route of Administration: , Injection
Citation: Hassanzadeh P, et al. The endocannabinoid system and NGF are involved in the mechanism of action of resveratrol: a multi-target nutraceutical with therapeutic potential in neuropsychiatric disorders. Psychopharmacology (Berl). 2016; 233:1087-96. doi: 10.1007/s00213-015-4188-3
Authors: Hassanzadeh P, Arbabi E, Atyabi F, Dinarvand R
